Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Allogeneic Stem Cell Transplant for Hematologic Malignancies
NCT00004145Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Nov 1998
- Primary completion
- Nov 2003
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide, antithymocyte globulin rabbit in leukemia, lymphoma, multiple myeloma (MM), myelodysplastic syndrome (MDS), sponsored by University of Chicago. Started Nov 1998; status: completed.
02
Drugs
fludarabinecyclophosphamideantithymocyte globulin rabbit
03
Conditions
leukemialymphomamultiple myeloma (MM)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00004145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004145.